|
Category
|
Any HPV 16 positivea
|
Any HPV 16 and/or 18 positivea
|
Other HR HPV without HPV 16 and/or 18
|
|---|
|
CIN 2
|
CIN 3
|
CIN 2/3
|
CIN 2
|
CIN 3
|
CIN 2/3
|
CIN 2
|
CIN 3
|
CIN 2/3
|
|---|
|
OR (95 % CI)
|
OR (95 % CI)
|
OR (95 % CI)
|
OR (95 % CI)
|
OR (95 % CI)
|
OR (95 % CI)
|
OR (95 % CI)
|
OR (95 % CI)
|
OR (95 % CI)
|
|---|
|
Non-Māori, 20–29 years
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
1.0
|
|
Non-Māori, 30–39 years
|
0.8 (0.4–1.5)
|
0.5 (0.2–1.2)
|
0.6 (0.4–1.1)
|
0.8 (0.4–1.6)
|
0.5 (0.2–1.2)
|
0.6 (0.4–1.1)
|
1.4 (0.7–2.9)
|
2.1 (0.8–5.2)
|
1.7 (0.9–3.0)
|
|
Non-Māori, 40–69 years
|
0.6 (0.3–1.5)
|
0.2 (0.1–0.6)
|
0.4 (0.2–0.8)
|
0.5 (0.2–1.3)
|
0.4 (0.1–1.1)
|
0.4 (0.2–0.9)
|
2.0 (0.8–5.0)
|
2.2 (0.7–6.9)
|
2.1 (1.1–4.3)
|
|
Māori, 20–29 years
|
0.8 (0.4–1.7)
|
0.7 (0.3–1.6)
|
0.7 (0.4–1.3)
|
0.6 (0.3–1.4)
|
0.5 (0.2–1.2)
|
0.6 (0.3–1.0)
|
1.7 (0.8–3.7)
|
2.1 (0.8–5.4)
|
1.8 (1.0–3.4)
|
|
Māori, 30–39 years
|
0.9 (0.3–2.4)
|
0.4 (0.2–1.1)
|
0.7 (0.3–1.3)
|
1.2 (0.4–3.7)
|
0.6 (0.2–1.9)
|
0.9 (0.4–2.0)
|
0.9 (0.3–2.6)
|
1.6 (0.5–4.7)
|
1.1 (0.5–2.4)
|
|
Māori, 40–69 years
|
1.4 (0.4–4.1)
|
0.4 (0.1–1.9)
|
0.8 (0.3–2.1)
|
1.7 (0.5–5.9)
|
0.8 (0.1–4.4)
|
1.2 (0.5–3.3)
|
0.6 (0.2–2.2)
|
1.3 (0.2–7.1)
|
0.8 (0.3–2.3)
|
|
Test for interactionb
|
P = 0.36
|
P = 0.52
|
P = 0.16
|
P = 0.09
|
P = 0.22
|
P = 0.02
|
P = 0.07
|
P = 0.27
|
P = 0.02
|
- Other HR HPV types include infection with either type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 or 68, not 16 or 18
- aRegardless of co-infection with other HPV types
- bLogistic regression including an interaction term for ethnicity and age group
